Biosensor imaging in preclinical pancreatic cancer targeting: taking cancer targeting to new dimensions. [ 2018 - ]

Research Grant

Researchers: A/Pr Paul Timpson (Principal investigator)

Brief description Using cutting-edge imaging technology and 3D models that mimic cancer, we can map areas of poor drug response within distinct 'stages' or regions of tumours. Here, we pinpoint and specifically target key factors limiting efficient drug response in order to improve the encouraging anti-cancer profile of new or current drugs in pancreatic cancer.

Funding Amount $640,210.00

Funding Scheme Research Fellowships

Notes Research Fellowship